ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2706

Association of Body Mass Index with Juvenile Idiopathic Arthritis Disease Activity: A Portuguese and Brazilian Collaborative Analysis with Data from Reuma.pt Registry

Agna Neto1, Ana Filipa Mourão 2, Filipa Oliveira-Ramos 3, Raquel Marques 3, Paula Estanqueiro 4, Manuel Salgado 4, Margarida Guedes 5, Daniela Piotto 6, Clovis Artur Silva 7, José Melo Gomes 8, Marta Cabral 9, Marta Conde 10, Ricardo Figueira 11, Maria José Santos 12, João Eurico Fonseca 13, Maria Teresa Terreri 6 and Helena Canhão 14, 1Rheumatology Department, Hospital de Egas Moniz, Centro Hospitalar de Lisboa Ocidental; CEDOC, NOVA Medical School, Faculdade de Ciências Médicas, Lisbon; Hospital Central do Funchal, Madeira., Lisbon, Portugal, 2Rheumatology Department, Hospital de Egas Moniz, Centro Hospitalar de Lisboa Ocidental; CEDOC, NOVA Medical School, Faculdade de Ciências Médicas, Lisbon, Lisbon, Portugal, 3Rheumatology and Metabolic Bone Diseases, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte; Rheumatology Research Unit, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Centro Académico de Medicina de Lisboa, Lisbon, Lisbon, Portugal, 4Pediatrics, Hospital Pediátrico Carmona da Mota, Coimbra, Coimbra, Portugal, 5Unidade de Imunologia Clínica, Centro Hospitalar Universitário do Porto, Porto, Portugal, 6Pediatric Rheumatology Unit, Universidade Federal de São Paulo, São Paulo, Brazil, 7Universidade de São Paulo, São Paulo, Brazil, 8Instituto Português de Reumatologia; Clínica Dr. Melo Gomes, Lisbon., Lisbon, Portugal, 9Pediatrics, Hospital Prof. Doutor Fernando Fonseca, Lisbon, Lisbon, Portugal, 10Pediatric Rheumatology Unit, Hospital Dona Estefânia, Centro Hospitalar de Lisboa Central, Lisbon, Lisbon, Portugal, 11Rheumatology Department, Hospital Central do Funchal, Funchal, Madeira, Portugal, 12Rheumatology department, Hospital Garcia de Orta, Almada, Portugal, 13Rheumatology and Bone Diseases Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte; Unidade de Investigação em Reumatologia, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa; Centro Académico de Medicina de Lisboa; Lisbon, Portugal., Lisbon, Portugal, 14CEDOC, EpiDoC Unit, NOVA Medical School, Lisbon, Lisbon, Portugal

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Disease Activity and body mass index, juvenile idiopathic arthritis (JIA)

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 12, 2019

Title: Pediatric Rheumatology – ePoster III: Systemic JIA, Fever, & Vasculitis

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: In adults with Rheumatoid Arthritis, obesity has been associated with higher disease activity. However, in Juvenile Idiopathic Arthritis (JIA), the influence of body mass index (BMI) on disease activity is uncertain and a previous study has failed to find any association. We aim to clarify the relationship between BMI and JIA disease activity.

Methods: An international, multicenter, observational analysis was conducted. JIA patients (according to ILAR criteria) aged ≤ 18 years, registered at Rheumatic Diseases Portuguese Register (Reuma.pt) in Portugal and Brazil were included. Anonymized data of the first registered visit was analyzed. Age- and sex-specific BMI percentiles (P) were calculated based on WHO growth standard charts and categorized into underweight (P< 3), normal weight (3≤P≤85), overweight (85< P≤97) and obesity (P >97). Disease activity was assessed by Juvenile Arthritis Disease Activity Score (JADAS-27). Univariate linear regression was used to examine the association of BMI categories with JADAS-27. Two multivariate regression models were performed: a) adjusting for gender, ethnicity, country, disease duration and JIA category (model 1); b) adjusting for those covariates plus use of oral glucocorticoids (GC) and DMARDs (model 2).

Results: 275 patients included, mean age 10.2±4.6 years, mean disease duration 6.1±4.9 years; 62% female. Thirty-two percent were persistent oligoarticular, 8% extended oligoarticular, 26% RF- polyarticular, 7% RF+ polyarticular­­, 6% systemic, 15% enthesitis-related arthritis, 5% psoriatic arthritis and 1% undifferentiated arthritis. The prevalence of underweight, normal weight, overweight and obesity was 6.9%, 67.3%, 15.3% and 10.5%, respectively. In the univariate linear regression, underweight was significantly associated with higher JADAS-27, compared to normal weight (p< 0.001), overweight (p< 0.001) and obesity (p=0.003). Younger age (p=0.013), shorter disease duration (p=0.001), black race ( p=0.026), living in Brazil (p=0.001), RF- polyarthritis (p< 0.001), RF+ polyarthritis (p< 0.001), the absence of DMARD therapy (, p< 0.001) and the use of GC (p=0.017) were also associated with higher JADAS-27 (table 1). In the model 1 of multivariate analysis, the same variables, except the country, remained significantly associated with higher disease activity. When GC and DMARD therapies were added to the model (model 2), the association of normal weight (p< 0.001), overweight (p< 0.001) and obesity (p=0.003) with lower disease activity persisted significant, compared to underweight patients, as well as those under DMARD therapy (p< 0.001). RF- (p=0.006) and RF+ polyarthritis (p=0.024) and the use of oral GC (p=0.002) were associated with higher disease activity.

Conclusion: There seems to be an independent association between underweight and higher disease activity in JIA patients, suggesting that active disease can impair child’s weight gain. Longitudinal analysis are needed to confirm these findings and understand the underlying mechanisms of this association.

Table 1. Relationship between JADAS-27 -dependent variable- and demographic and clinical characteristics of JIA patients.


Disclosure: A. Neto, None; A. Mourão, None; F. Oliveira-Ramos, None; R. Marques, None; P. Estanqueiro, None; M. Salgado, None; M. Guedes, None; D. Piotto, None; C. Artur Silva, None; J. Melo Gomes, None; M. Cabral, None; M. Conde, None; R. Figueira, None; M. Santos, AbbVie, 8, Biogen, 8, Novartis, 8, Pfizer, 8, Roche, 8; J. Eurico Fonseca, None; M. Terreri, None; H. Canhão, None.

To cite this abstract in AMA style:

Neto A, Mourão A, Oliveira-Ramos F, Marques R, Estanqueiro P, Salgado M, Guedes M, Piotto D, Artur Silva C, Melo Gomes J, Cabral M, Conde M, Figueira R, Santos M, Eurico Fonseca J, Terreri M, Canhão H. Association of Body Mass Index with Juvenile Idiopathic Arthritis Disease Activity: A Portuguese and Brazilian Collaborative Analysis with Data from Reuma.pt Registry [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/association-of-body-mass-index-with-juvenile-idiopathic-arthritis-disease-activity-a-portuguese-and-brazilian-collaborative-analysis-with-data-from-reuma-pt-registry/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/association-of-body-mass-index-with-juvenile-idiopathic-arthritis-disease-activity-a-portuguese-and-brazilian-collaborative-analysis-with-data-from-reuma-pt-registry/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology